Report of Foreign Issuer (6-k)

---

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 or 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

FOR THE MONTH OF MAY 2019

Commission File Number: 000-29338

CORREVIO PHARMA CORP.
(Translation of registrant’s name into English)

1441 Creekside Drive, 6th Floor
Vancouver, BC V6J 4S7, CANADA
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F

Form 20-F [   ] Form 40-F [ X ]

Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [   ]

Indicate by check mark whether the registrant is "submitting" the Form 6-K in paper as permitted by Regulation S-T "Rule" 101(b)(7): [   ]

---

Exhibit	Description
99.1	Notice of Annual Meeting of Shareholders
99.2	Management Information circular
99.3	Form of Proxy
99.4	Voting Instructions Form
99.5	NI Card

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: May 21, 2019

	CORREVIO PHARMA CORP.
	(Registrant)
	By:	/s/ Justin Renz
	Name:	Justin Renz
	Title:	President and Chief Financial Officer

---